XML 118 R102.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Segment Information - Capital Expenditure and Depreciation and Amortization by Segment (Detail) - USD ($) $ in Millions | 12 Months Ended
--- | ---
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019
Segment Reporting Information [Line Items] |  |  |
Capital Expenditures | $ 393 | $ 192 | $ 236
Depreciation and amortization | 1,156 | 325 | 323
Operating Segments [Member] | Nourish |  |  |
Segment Reporting Information [Line Items] |  |  |
Capital Expenditures | 183 | 98 | 126
Depreciation and amortization | 594 | 211 | 210
Operating Segments [Member] | Health & Biosciences |  |  |
Segment Reporting Information [Line Items] |  |  |
Capital Expenditures | 139 | 7 | 8
Depreciation and amortization | 353 | 36 | 34
Operating Segments [Member] | Scent [Member] |  |  |
Segment Reporting Information [Line Items] |  |  |
Capital Expenditures | 41 | 87 | 102
Depreciation and amortization | 84 | 78 | 79
Operating Segments [Member] | Pharma Solutions |  |  |
Segment Reporting Information [Line Items] |  |  |
Capital Expenditures | 30 | 0 | 0
Depreciation and amortization | $ 125 | $ 0 | $ 0

X
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=iff_NourishMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=iff_HealthBiosciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=iff_ScentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=iff_PharmaSolutionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |